Jiangsu, China

Lijuan Zhai

This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Hengrui Medicine Company Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lijuan Zhai. Retrieved from https://idiyas.com/inventor/lijuan-zhai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lijuan Zhai: Innovator in Pharmaceutical Chemistry

Introduction

Lijuan Zhai is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new compounds for clinical applications. His work focuses on enhancing the stability and efficacy of pharmaceutical agents.

Latest Patents

Lijuan Zhai holds a patent for a crystalline form of an alkynyl pyridine prolyl hydroxylase inhibitor. This invention includes a method for preparing the crystalline form, which is represented by a specific formula. The new crystalline form demonstrates good stability, making it a promising candidate for clinical treatment.

Career Highlights

Zhai is associated with Jiangsu Hengrui Medicine Company Ltd., where he continues to advance his research and development efforts. His innovative approach has led to breakthroughs in the pharmaceutical industry, particularly in the synthesis of stable compounds.

Collaborations

Zhai collaborates with esteemed colleagues, including Zhenxing Du and Likun Wang, who contribute to his research endeavors. Their combined expertise enhances the potential for successful outcomes in their projects.

Conclusion

Lijuan Zhai's contributions to pharmaceutical chemistry exemplify the impact of innovative research on clinical treatments. His work not only advances scientific knowledge but also holds promise for improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…